MCI
LLY icon

MRP Capital Investments’s Eli Lilly LLY Stock Holding History

MRP Capital Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Sell
2,932
-45
-2% -$46K 2.59% 10
2026
Q1 		$2.74M Buy
2,977
+70
+2% +$71K 2.39% 10
2025
Q4 		$3.12M Buy
2,907
+770
+36% +$736K 2.62% 7
2025
Q3 		$1.67M Sell
2,137
-960
-31% -$714K 1.43% 24
2025
Q2 		$2.41M Buy
3,097
+130
+4% +$101K 1.66% 14
2025
Q1 		$2.45M Sell
2,967
-10
-0.3% -$8.32K 2.29% 10
2024
Q4 		$2.3M Buy
2,977
+200
+7% +$166K 2.09% 13
2024
Q3 		$2.46M Sell
2,777
-178
-6% -$160K 2.34% 7
2024
Q2 		$2.68M Sell
2,955
-175
-6% -$140K 2.5% 7
2024
Q1 		$2.44M Sell
3,130
-210
-6% -$149K 2.44% 8
2023
Q4 		$1.95M Sell
3,340
-3,241
-49% -$1.89M 2.09% 9
2023
Q3 		$3.65M Buy
6,581
+3,003
+84% +$1.55M 4.04% 2
2023
Q2 		$1.68M Buy
+3,578
New +$1.5M 1.64% 10
2023
Q1 		– Sell
-3,482
Closed -$1.27M – 250
2022
Q4 		$1.27M Buy
+3,482
New +$1.23M 1.41% 25

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MRP Capital Investments's LLY Position: Q2 2026 in Review

MRP Capital Investments reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $46K and leaving 2,932 shares worth $3.52M. The position accounts for 2.59% of the portfolio, ranked #10.

MRP Capital Investments first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.65M in Q3 2023. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MRP Capital Investments held 2,932 shares of Eli Lilly worth $3.52M as of Q2 2026.
  • MRP Capital Investments sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
  • Eli Lilly made up 2.59% of MRP Capital Investments's portfolio in Q2 2026, its #10 holding.
  • MRP Capital Investments first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • MRP Capital Investments's Eli Lilly position peaked at $3.65M in Q3 2023.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.